What are the effects of cannabis on the cardiovascular system? Dr. Chandy helps clear the haze. The American Heart Association has established the facts.
Dr. Mark Chandy earned his MD and Ph.D. in 2008, at Pennsylvania State University. After completing
medical school, Dr. Chandy trained in Internal Medicine at the University of British Columbia, followed
by a Cardiology fellowship at the University of Toronto. He also completed a fellowship in
Echocardiography and enrolled in the Clinician Scientist Training Program at the University of Toronto.
With a desire to learn stem cell biology, Dr. Chandy trained in induced pluripotent stem cells (iPSCs)
disease modeling at Stanford University. Dr. Chandy’s research has been published in Cell and other
high-impact journals. He holds patents for his novel discoveries. As a recently appointed Assistant
Professor at the University of Western Ontario, Dr. Chandy is an independent physician-scientist using
iPSC disease modeling, next-generation sequencing (NGS), proteomics, and gene editing to
understand the mechanisms of cardiovascular disease. Dr. Chandy's current research focuses on
understanding the pathophysiology of environmental exposures such as air pollution, e-cigarettes, and
cannabis on cardiovascular disease using human iPSC-derived tissue. The overarching goal of his
research is to 1) investigate the effects of the environment on the cardiovascular system, 2) discover
biomarkers to risk stratify patients, and 3) discover druggable target genes for cardiovascular disease.
The relationship between cannabis and cardiovascular disease: clearing the haze. Nature Reviews. Jan 2025
Addiction Medicine intersects with all aspects of medicine from primary care, pediatrics, OBGYN, surgery, cardiology, gastroenterology, and of course, emergency medicine. Building up the...
Libby Jones is the Program Director of Global Health Advocacy Incubator, GHAI’s Overdose Prevention Initiative. Libby leads the Initiative’s advocacy efforts, advancing federal policies...
Was I duped by Big Pharma? Early in my career I was told “You and your colleagues are undertreating pain.” When I served as...